CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for OraSure Technologies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

OraSure Technologies Inc
220 E First St
Phone: (503) 641-6115p:503 641-6115 BETHLEHEM, PA  18015  United States Ticker: OSUROSUR
Business Summary
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024YesYes--Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board John P.Kenny 56 10/28/2025 9/9/2024
President, Chief Executive Officer, Director CarrieEglinton Manner 51 6/4/2022 6/4/2022
Chief Financial Officer Kenneth J.Mcgrath 53 8/8/2022 8/8/2022
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Sense Biodetection Limited 29 and 30 The Quadrant United Kingdom
Sherlock Biosciences Inc 200 Talcott Avenue Watertown MA United States
DNA Genotek, Inc. 2 Beaverbrook Road Kanata ON Canada

Business Names
Business Name
221B Foundation
DNA Genotek Inc.
OSUR
5 additional Business Names available in full report.

General Information
Number of Employees: 501 (As of 12/31/2024)
Outstanding Shares: 71,733,530 (As of 10/31/2025)
Shareholders: 22,476
Stock Exchange: NASD
Federal Tax Id: 364370966
Fax Number: (610) 882-1830
Email Address: smorin@orasure.com


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 6, 2025